未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Sacituzumab Tirumotecan in EGFR-TKI-Resistant, EGFR-Mutated Advanced NSCLC
Fang, Wenfeng; Wu, Lin; Meng, Xiangjiao; Yao, Yu; Zuo, Wei; Yao, Wenxiu; Xie, Yanyan; Zhang, Yu; Cui, Jiuwei; Zhang, Yongchang; Li, Xingya; Zhuang, Wu; Fang, Jian; Wang, Qiming; Jiang, Wei; Li, Kai; Bai, Yuju; Luo, Yongzhong; Ma, Fang; Yu, Yan; Zheng, Wei; Liu, Zhentian; Yang, Bin; Ma, Rui; Fang, Yong; Yang, Runxiang; Jiang, Liyan; Hu, Jie; Yang, Jiacheng; Diao, Yina; Jin, Xiaoping; Ge, Junyou; Yang, Yunpeng; Zhang, Li
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Efficacy and safety of finotonlimab plus docetaxel vs. docetaxel in previously treated advanced squamous cell non-small-cell lung cancer: a randomized, double-blinded, phase III trialfinotonlimab联合多西他赛对比多西他赛治疗既往经治的晚期鳞状细胞非小细胞肺癌的疗效与安全性:一项随机、双盲、III期临床试验
Han, Baohui; Wu, Lin; Yang, Runxiang; Wu, Hongbo; Li, Wei; Yu, Yan; Zhang, Mingjuan; Sun, Hongmei; Chu, Tianqing; Zhong, Fukuan; Fang, Yong; Wu, Rong; Bian, Tao; Guo, Xiaoqing; Sun, Meili; Zhang, Yanming; Liu, Lianke; Liu, Xuewen; Pan, Yueyin; Jiang, Ou; Wei, Zonghui; Lin, Haifeng; Guo, Wei; Fang, Jian; Wang, Jialei; Ding, Cuimin; Hu, Yanping; Ye, Feng; Zhuang, Wu; Ye, Shucheng; Wang, Lihong; Huang, Zhe; Liu, Chang; Yang, Ling; Wang, Jinling; Xie, Liangzhi
分享
收藏
分享
收藏The efficacy and safety of suvemcitug, envafolimab, and FOLFIRI in microsatellite-stable or mismatch repair-proficient colorectal cancer: preliminary results of a phase 2 studysuvemcitug、envafolimab和FOLFIRI在微卫星稳定或错配修复 proficient 结直肠癌中的有效性与安全性:一项2期研究的初步结果
Liu, Ying; Wang, Jufeng; Fang, Yong; Deng, Yanhong; Hu, Changlu; Fan, Qingxia; Gu, Kangsheng; Zhang, Yu; Yang, Chen; Liu, Zhenru; Tian, Ji; Sun, Xiyang; Sun, Shuguang
分享
收藏
分享
收藏
分享
收藏
分享
收藏